| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 15 | 2020 | 132 | 3.040 |
Why?
|
| Calpain | 43 | 2016 | 205 | 2.410 |
Why?
|
| Myelin Sheath | 39 | 2013 | 115 | 2.030 |
Why?
|
| Sphingolipids | 9 | 2020 | 337 | 1.590 |
Why?
|
| Natural Killer T-Cells | 4 | 2017 | 7 | 1.560 |
Why?
|
| Brain | 44 | 2010 | 2176 | 1.240 |
Why?
|
| Spinal Cord Injuries | 36 | 2004 | 551 | 1.140 |
Why?
|
| Galactosylceramides | 7 | 2015 | 12 | 1.020 |
Why?
|
| Gangliosides | 23 | 2000 | 29 | 1.020 |
Why?
|
| Spinal Cord | 32 | 2000 | 244 | 0.950 |
Why?
|
| Glycosphingolipids | 15 | 2007 | 51 | 0.890 |
Why?
|
| Sphingosine | 6 | 2012 | 315 | 0.830 |
Why?
|
| Brain Chemistry | 15 | 2007 | 173 | 0.820 |
Why?
|
| Animals | 135 | 2017 | 20881 | 0.720 |
Why?
|
| Muscles | 15 | 1994 | 158 | 0.690 |
Why?
|
| Ceramides | 7 | 2016 | 578 | 0.670 |
Why?
|
| Glycolipids | 7 | 2010 | 20 | 0.650 |
Why?
|
| Rats | 70 | 2016 | 5300 | 0.640 |
Why?
|
| Myelin Proteins | 15 | 1998 | 21 | 0.590 |
Why?
|
| Autoimmunity | 1 | 2017 | 118 | 0.560 |
Why?
|
| Myelin Basic Protein | 12 | 1997 | 62 | 0.560 |
Why?
|
| Phospholipids | 10 | 2009 | 108 | 0.530 |
Why?
|
| Neurons | 13 | 2016 | 881 | 0.500 |
Why?
|
| Autoantigens | 1 | 2015 | 91 | 0.490 |
Why?
|
| Calcium | 17 | 2003 | 929 | 0.480 |
Why?
|
| Inflammation | 4 | 2017 | 1030 | 0.460 |
Why?
|
| Chromatography, Thin Layer | 21 | 2001 | 52 | 0.460 |
Why?
|
| Apoptosis | 14 | 2012 | 1641 | 0.430 |
Why?
|
| Sulfoglycosphingolipids | 7 | 2009 | 8 | 0.400 |
Why?
|
| Cattle | 20 | 2010 | 475 | 0.400 |
Why?
|
| G(M1) Ganglioside | 6 | 1992 | 8 | 0.370 |
Why?
|
| Lysophospholipids | 1 | 2012 | 209 | 0.370 |
Why?
|
| Mice, Quaking | 8 | 1997 | 12 | 0.360 |
Why?
|
| Cerebrospinal Fluid | 1 | 2010 | 23 | 0.350 |
Why?
|
| Cysteine Proteinase Inhibitors | 8 | 2016 | 73 | 0.340 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2008 | 1 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2016 | 2083 | 0.320 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1998 | 107 | 0.320 |
Why?
|
| Isoenzymes | 4 | 1998 | 308 | 0.310 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 626 | 0.290 |
Why?
|
| Mycoplasma | 1 | 2007 | 10 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 12 | 1999 | 290 | 0.280 |
Why?
|
| Mycoplasma Infections | 1 | 2007 | 40 | 0.280 |
Why?
|
| Microglia | 3 | 2016 | 143 | 0.280 |
Why?
|
| Central Nervous System Depressants | 1 | 2007 | 182 | 0.260 |
Why?
|
| Sialyltransferases | 4 | 1990 | 7 | 0.260 |
Why?
|
| Nerve Degeneration | 7 | 2009 | 134 | 0.260 |
Why?
|
| Central Nervous System | 2 | 2001 | 107 | 0.260 |
Why?
|
| Peptide Hydrolases | 4 | 1990 | 82 | 0.240 |
Why?
|
| Humans | 53 | 2020 | 68618 | 0.230 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2016 | 381 | 0.230 |
Why?
|
| Neurofilament Proteins | 6 | 2000 | 20 | 0.230 |
Why?
|
| Aging | 10 | 2009 | 911 | 0.230 |
Why?
|
| Epoprostenol | 6 | 1992 | 71 | 0.220 |
Why?
|
| Signal Transduction | 2 | 2012 | 2689 | 0.220 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2002 | 282 | 0.220 |
Why?
|
| Sphingomyelins | 7 | 2009 | 106 | 0.220 |
Why?
|
| Neuroprotective Agents | 4 | 2016 | 317 | 0.210 |
Why?
|
| Lipopolysaccharides | 3 | 2010 | 455 | 0.210 |
Why?
|
| Nervous System Diseases | 4 | 2009 | 142 | 0.210 |
Why?
|
| Phosphatidylinositols | 4 | 1996 | 40 | 0.210 |
Why?
|
| Membrane Lipids | 3 | 2009 | 31 | 0.200 |
Why?
|
| Caseins | 3 | 2000 | 19 | 0.200 |
Why?
|
| Methylprednisolone | 3 | 1999 | 99 | 0.200 |
Why?
|
| Carbohydrate Sequence | 10 | 2013 | 45 | 0.200 |
Why?
|
| Brain Ischemia | 4 | 1993 | 665 | 0.190 |
Why?
|
| Kininogens | 2 | 1999 | 88 | 0.190 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 163 | 0.190 |
Why?
|
| Molecular Sequence Data | 11 | 2013 | 1447 | 0.190 |
Why?
|
| Female | 34 | 2020 | 38074 | 0.190 |
Why?
|
| Cerebrosides | 12 | 2013 | 13 | 0.190 |
Why?
|
| Ethanol | 1 | 2007 | 893 | 0.190 |
Why?
|
| Mice | 29 | 2007 | 8474 | 0.180 |
Why?
|
| Indomethacin | 2 | 2000 | 107 | 0.180 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2000 | 73 | 0.180 |
Why?
|
| Neuroglia | 6 | 2007 | 136 | 0.180 |
Why?
|
| Oligodendroglia | 3 | 2016 | 107 | 0.180 |
Why?
|
| Muscular Dystrophy, Animal | 3 | 1986 | 4 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1998 | 250 | 0.180 |
Why?
|
| Schwann Cells | 3 | 1999 | 33 | 0.180 |
Why?
|
| Interferon-gamma | 3 | 2016 | 241 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 384 | 0.170 |
Why?
|
| Leucine | 5 | 2001 | 41 | 0.170 |
Why?
|
| Ganglia, Spinal | 1 | 1999 | 29 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 2 | 1998 | 108 | 0.170 |
Why?
|
| Glycoproteins | 4 | 2003 | 238 | 0.170 |
Why?
|
| Immunohistochemistry | 8 | 2002 | 1174 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 7 | 2010 | 346 | 0.170 |
Why?
|
| Cytokines | 3 | 2017 | 866 | 0.160 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 7 | 1993 | 18 | 0.160 |
Why?
|
| Enzyme Activation | 8 | 2016 | 791 | 0.160 |
Why?
|
| Rats, Inbred Strains | 17 | 1992 | 532 | 0.150 |
Why?
|
| T-Lymphocytes | 6 | 2009 | 597 | 0.150 |
Why?
|
| Demyelinating Diseases | 7 | 1997 | 57 | 0.150 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 112 | 0.150 |
Why?
|
| Mice, Neurologic Mutants | 3 | 1986 | 23 | 0.150 |
Why?
|
| Endopeptidases | 6 | 1987 | 52 | 0.140 |
Why?
|
| Diffuse Cerebral Sclerosis of Schilder | 6 | 1972 | 15 | 0.140 |
Why?
|
| Oligodendroglioma | 1 | 2016 | 18 | 0.140 |
Why?
|
| Male | 28 | 2020 | 37321 | 0.140 |
Why?
|
| Detergents | 3 | 1993 | 34 | 0.140 |
Why?
|
| Disease Models, Animal | 13 | 2007 | 2550 | 0.130 |
Why?
|
| Antigens, CD1d | 1 | 2015 | 2 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2020 | 1330 | 0.130 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1997 | 186 | 0.130 |
Why?
|
| Cells, Cultured | 9 | 2007 | 2673 | 0.130 |
Why?
|
| Thrombin | 1 | 1995 | 117 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 234 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1995 | 195 | 0.120 |
Why?
|
| Astrocytes | 3 | 1996 | 270 | 0.120 |
Why?
|
| Subcellular Fractions | 7 | 1992 | 92 | 0.120 |
Why?
|
| Cell Fractionation | 3 | 1992 | 34 | 0.120 |
Why?
|
| Sciatic Nerve | 4 | 1983 | 26 | 0.120 |
Why?
|
| Cytosol | 6 | 1996 | 123 | 0.120 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 1987 | 22 | 0.120 |
Why?
|
| Kinetics | 9 | 1996 | 1047 | 0.120 |
Why?
|
| Fish Oils | 2 | 1993 | 21 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 12 | 2002 | 272 | 0.120 |
Why?
|
| Immunoglobulin G | 4 | 1999 | 481 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 901 | 0.110 |
Why?
|
| Capillary Permeability | 4 | 1993 | 69 | 0.110 |
Why?
|
| Clonal Anergy | 1 | 2013 | 4 | 0.110 |
Why?
|
| DNA | 5 | 1990 | 597 | 0.110 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2013 | 6 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 6 | 2004 | 114 | 0.110 |
Why?
|
| Leukotriene B4 | 3 | 1990 | 17 | 0.110 |
Why?
|
| Dipeptides | 6 | 2016 | 89 | 0.110 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 19 | 0.110 |
Why?
|
| Enzyme Inhibitors | 4 | 1998 | 659 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 2 | 2016 | 102 | 0.110 |
Why?
|
| Thromboxane A2 | 4 | 1986 | 88 | 0.100 |
Why?
|
| Lipid Metabolism | 2 | 2007 | 186 | 0.100 |
Why?
|
| Molecular Weight | 9 | 1997 | 358 | 0.100 |
Why?
|
| Propylene Glycols | 1 | 2012 | 16 | 0.100 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2012 | 29 | 0.100 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2012 | 17 | 0.100 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2012 | 24 | 0.100 |
Why?
|
| Polyethylene Glycols | 5 | 1993 | 149 | 0.100 |
Why?
|
| Chromatography, Ion Exchange | 5 | 2000 | 73 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 65 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 3 | 1992 | 296 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 4848 | 0.100 |
Why?
|
| Mice, Jimpy | 2 | 1997 | 5 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2013 | 489 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2000 | 133 | 0.100 |
Why?
|
| Phosphatidylcholines | 3 | 1989 | 38 | 0.100 |
Why?
|
| Hydrolysis | 4 | 2004 | 144 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 507 | 0.100 |
Why?
|
| Myelin Proteolipid Protein | 3 | 1991 | 20 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 1995 | 371 | 0.100 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1991 | 10 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 248 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 710 | 0.090 |
Why?
|
| Antibodies | 2 | 2010 | 241 | 0.090 |
Why?
|
| Neuroblastoma | 2 | 1989 | 109 | 0.090 |
Why?
|
| Lipids | 7 | 1991 | 298 | 0.090 |
Why?
|
| Acetylcholine | 1 | 1990 | 64 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 167 | 0.090 |
Why?
|
| Glycoconjugates | 1 | 1990 | 22 | 0.090 |
Why?
|
| In Vitro Techniques | 5 | 1997 | 765 | 0.090 |
Why?
|
| Middle Aged | 6 | 2020 | 21147 | 0.090 |
Why?
|
| Mycoplasma fermentans | 1 | 2010 | 1 | 0.090 |
Why?
|
| Cross Reactions | 1 | 2010 | 57 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 2 | 1987 | 12 | 0.090 |
Why?
|
| Lead Poisoning | 3 | 1974 | 23 | 0.090 |
Why?
|
| Acetylation | 1 | 2010 | 94 | 0.090 |
Why?
|
| Aged | 7 | 2020 | 14862 | 0.090 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 85 | 0.090 |
Why?
|
| Mutation | 9 | 1984 | 1213 | 0.090 |
Why?
|
| Globosides | 1 | 1989 | 2 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 42 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2004 | 160 | 0.080 |
Why?
|
| Cerebral Hemorrhage | 2 | 1989 | 198 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 7 | 1991 | 618 | 0.080 |
Why?
|
| Isotope Labeling | 3 | 1984 | 30 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 284 | 0.080 |
Why?
|
| Brain Neoplasms | 3 | 2002 | 371 | 0.080 |
Why?
|
| Rabbits | 5 | 2007 | 509 | 0.080 |
Why?
|
| Immunoblotting | 4 | 1992 | 254 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 1991 | 320 | 0.080 |
Why?
|
| Genes | 1 | 1988 | 86 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2000 | 562 | 0.080 |
Why?
|
| Erythrocytes | 3 | 1994 | 137 | 0.080 |
Why?
|
| Rheumatic Fever | 1 | 1987 | 2 | 0.080 |
Why?
|
| Blood Glucose | 1 | 1991 | 631 | 0.080 |
Why?
|
| Chorea | 1 | 1987 | 4 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2010 | 368 | 0.080 |
Why?
|
| Cell Membrane | 5 | 1992 | 525 | 0.080 |
Why?
|
| Calcimycin | 5 | 2000 | 32 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 306 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2000 | 59 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 135 | 0.070 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2007 | 27 | 0.070 |
Why?
|
| Spinal Cord Diseases | 2 | 1984 | 23 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2008 | 230 | 0.070 |
Why?
|
| Blood Vessels | 4 | 1993 | 102 | 0.070 |
Why?
|
| Corpus Callosum | 1 | 1987 | 29 | 0.070 |
Why?
|
| SRS-A | 2 | 1986 | 20 | 0.070 |
Why?
|
| Disease Progression | 2 | 2008 | 1038 | 0.070 |
Why?
|
| Lithium | 1 | 2007 | 76 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2004 | 282 | 0.070 |
Why?
|
| Apoproteins | 1 | 1986 | 11 | 0.070 |
Why?
|
| Parkinson Disease | 2 | 2002 | 272 | 0.070 |
Why?
|
| Fatty Acids | 4 | 1987 | 222 | 0.070 |
Why?
|
| Octoxynol | 3 | 1993 | 19 | 0.070 |
Why?
|
| Transferases | 1 | 1986 | 14 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 1998 | 150 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 4 | 1989 | 167 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2007 | 150 | 0.070 |
Why?
|
| Lactosylceramides | 1 | 1986 | 27 | 0.070 |
Why?
|
| Glioma | 3 | 1999 | 140 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 1986 | 50 | 0.070 |
Why?
|
| RNA, Messenger | 7 | 2002 | 1664 | 0.070 |
Why?
|
| Muscular Diseases | 2 | 1984 | 41 | 0.070 |
Why?
|
| Chick Embryo | 4 | 1989 | 379 | 0.070 |
Why?
|
| Cell Differentiation | 5 | 2009 | 1034 | 0.060 |
Why?
|
| Brain Stem | 3 | 1999 | 46 | 0.060 |
Why?
|
| Multienzyme Complexes | 2 | 1997 | 50 | 0.060 |
Why?
|
| Caspases | 2 | 2003 | 194 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 2 | 1997 | 39 | 0.060 |
Why?
|
| Protease Inhibitors | 3 | 2001 | 76 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 1989 | 617 | 0.060 |
Why?
|
| Models, Neurological | 1 | 1986 | 136 | 0.060 |
Why?
|
| Chickens | 6 | 1994 | 232 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 1995 | 1293 | 0.060 |
Why?
|
| Neoplasms | 3 | 2015 | 1667 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2003 | 111 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 2002 | 301 | 0.060 |
Why?
|
| Adult | 12 | 2013 | 21403 | 0.060 |
Why?
|
| Carbohydrate Conformation | 4 | 1996 | 25 | 0.060 |
Why?
|
| Axons | 7 | 1988 | 139 | 0.060 |
Why?
|
| Brain Diseases | 3 | 1980 | 78 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2003 | 174 | 0.060 |
Why?
|
| Time Factors | 8 | 2002 | 4655 | 0.060 |
Why?
|
| Autoradiography | 3 | 1989 | 94 | 0.060 |
Why?
|
| Muscle Development | 1 | 1984 | 31 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 4 | 1999 | 511 | 0.060 |
Why?
|
| Cathepsin B | 3 | 1997 | 33 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2002 | 492 | 0.060 |
Why?
|
| Astrocytoma | 2 | 1980 | 30 | 0.060 |
Why?
|
| Cell Line | 4 | 1995 | 1752 | 0.050 |
Why?
|
| Cell Death | 3 | 2016 | 329 | 0.050 |
Why?
|
| Sialic Acids | 3 | 1994 | 27 | 0.050 |
Why?
|
| Mitochondria | 2 | 2009 | 643 | 0.050 |
Why?
|
| Ionophores | 2 | 2000 | 25 | 0.050 |
Why?
|
| AMP Deaminase | 1 | 1982 | 1 | 0.050 |
Why?
|
| Nucleotide Deaminases | 1 | 1982 | 1 | 0.050 |
Why?
|
| Stereotaxic Techniques | 1 | 2002 | 35 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 1980 | 49 | 0.050 |
Why?
|
| Plant Lectins | 2 | 1995 | 20 | 0.050 |
Why?
|
| Animals, Newborn | 4 | 1998 | 396 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2003 | 411 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 16 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2016 | 139 | 0.050 |
Why?
|
| Cerebral Cortex | 4 | 1996 | 415 | 0.050 |
Why?
|
| Nerve Fibers | 2 | 1999 | 77 | 0.050 |
Why?
|
| Organ Specificity | 2 | 1999 | 167 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 1998 | 92 | 0.050 |
Why?
|
| Transfection | 3 | 1997 | 782 | 0.050 |
Why?
|
| Pregnancy | 1 | 2007 | 2334 | 0.050 |
Why?
|
| Macrophages | 2 | 2002 | 647 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1991 | 15 | 0.050 |
Why?
|
| Young Adult | 2 | 2013 | 5717 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2003 | 155 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1995 | 138 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2009 | 718 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 5 | 1999 | 852 | 0.050 |
Why?
|
| Reference Values | 4 | 1995 | 579 | 0.050 |
Why?
|
| DNA Fragmentation | 4 | 2002 | 85 | 0.050 |
Why?
|
| Phagocytes | 1 | 2000 | 15 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 1994 | 234 | 0.040 |
Why?
|
| Hypertension | 1 | 1989 | 1535 | 0.040 |
Why?
|
| Enzyme Stability | 2 | 1990 | 30 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 1997 | 69 | 0.040 |
Why?
|
| Posterior Horn Cells | 1 | 1999 | 4 | 0.040 |
Why?
|
| Carbon Radioisotopes | 4 | 1986 | 34 | 0.040 |
Why?
|
| Necrosis | 3 | 2000 | 239 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2000 | 124 | 0.040 |
Why?
|
| Proteolipids | 1 | 1979 | 20 | 0.040 |
Why?
|
| Chromatography, Gas | 2 | 1997 | 31 | 0.040 |
Why?
|
| Solubility | 2 | 1989 | 134 | 0.040 |
Why?
|
| Oligosaccharides | 2 | 1994 | 26 | 0.040 |
Why?
|
| Tritium | 4 | 1984 | 101 | 0.040 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 3 | 1988 | 42 | 0.040 |
Why?
|
| Molecular Structure | 2 | 1997 | 397 | 0.040 |
Why?
|
| Thromboxane B2 | 3 | 1988 | 108 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 1998 | 5 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1998 | 44 | 0.040 |
Why?
|
| Polyradiculopathy | 1 | 1978 | 6 | 0.040 |
Why?
|
| Neutrophils | 4 | 1993 | 204 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 181 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 119 | 0.040 |
Why?
|
| Microsomes | 2 | 1993 | 31 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 134 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1998 | 201 | 0.040 |
Why?
|
| Protein Kinases | 1 | 1998 | 122 | 0.040 |
Why?
|
| Liver | 2 | 1993 | 1118 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 1978 | 175 | 0.040 |
Why?
|
| Immunochemistry | 1 | 1997 | 17 | 0.040 |
Why?
|
| Growth Substances | 1 | 1997 | 77 | 0.040 |
Why?
|
| Nervous System | 4 | 1989 | 45 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 2 | 1988 | 182 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 56 | 0.030 |
Why?
|
| Age Factors | 5 | 2004 | 1864 | 0.030 |
Why?
|
| Lewis X Antigen | 1 | 1996 | 2 | 0.030 |
Why?
|
| Carbamates | 1 | 2016 | 41 | 0.030 |
Why?
|
| Extracellular Vesicles | 1 | 2016 | 21 | 0.030 |
Why?
|
| Blotting, Western | 4 | 2002 | 954 | 0.030 |
Why?
|
| Nutrition Disorders | 1 | 1976 | 16 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 74 | 0.030 |
Why?
|
| Cerebral Infarction | 2 | 1987 | 103 | 0.030 |
Why?
|
| Exosomes | 1 | 2016 | 44 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2016 | 101 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2016 | 98 | 0.030 |
Why?
|
| Microtubule Proteins | 2 | 1987 | 4 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 196 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1997 | 131 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1995 | 60 | 0.030 |
Why?
|
| Immunologic Techniques | 3 | 1995 | 30 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1998 | 382 | 0.030 |
Why?
|
| Epitopes | 1 | 1976 | 146 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1995 | 88 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1995 | 72 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2016 | 116 | 0.030 |
Why?
|
| Microscopy, Electron | 5 | 2003 | 351 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 1975 | 22 | 0.030 |
Why?
|
| Species Specificity | 2 | 1987 | 303 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 1975 | 53 | 0.030 |
Why?
|
| Tyrosine | 1 | 1995 | 196 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 1083 | 0.030 |
Why?
|
| Monocytes | 1 | 1995 | 210 | 0.030 |
Why?
|
| Phosphorylation | 2 | 1995 | 1200 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 1995 | 397 | 0.030 |
Why?
|
| Calcium Chloride | 2 | 1984 | 38 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 1998 | 196 | 0.030 |
Why?
|
| Pyrrolidines | 1 | 1993 | 45 | 0.030 |
Why?
|
| Receptors, Opioid, kappa | 1 | 1993 | 37 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 1993 | 9 | 0.030 |
Why?
|
| Glycoside Hydrolases | 3 | 1994 | 25 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1993 | 86 | 0.030 |
Why?
|
| Taiwan | 3 | 2002 | 20 | 0.030 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 1993 | 3 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2013 | 16 | 0.030 |
Why?
|
| Brain Edema | 1 | 1993 | 50 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 1993 | 33 | 0.030 |
Why?
|
| Lectins | 2 | 1995 | 81 | 0.030 |
Why?
|
| Lipid Metabolism, Inborn Errors | 2 | 1974 | 6 | 0.030 |
Why?
|
| Food, Fortified | 1 | 1993 | 38 | 0.030 |
Why?
|
| Deoxycholic Acid | 1 | 1992 | 4 | 0.030 |
Why?
|
| Inositol Phosphates | 1 | 1992 | 28 | 0.030 |
Why?
|
| Carbachol | 1 | 1992 | 34 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 1992 | 13 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2003 | 233 | 0.030 |
Why?
|
| Catalase | 2 | 1989 | 85 | 0.030 |
Why?
|
| Thromboxanes | 3 | 1989 | 53 | 0.030 |
Why?
|
| Rodent Diseases | 1 | 1971 | 4 | 0.020 |
Why?
|
| Egtazic Acid | 2 | 1995 | 29 | 0.020 |
Why?
|
| Metallothionein | 1 | 1991 | 20 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1999 | 1070 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1851 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1992 | 276 | 0.020 |
Why?
|
| Superoxide Dismutase | 2 | 1989 | 149 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 1993 | 158 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1991 | 100 | 0.020 |
Why?
|
| Kinins | 1 | 1991 | 109 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 1991 | 15 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1991 | 31 | 0.020 |
Why?
|
| Dextrans | 1 | 1991 | 33 | 0.020 |
Why?
|
| Cholesterol | 4 | 1986 | 331 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1990 | 49 | 0.020 |
Why?
|
| Cell Extracts | 1 | 1990 | 21 | 0.020 |
Why?
|
| Sepharose | 1 | 1990 | 18 | 0.020 |
Why?
|
| Centrifugation | 1 | 1990 | 16 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2004 | 682 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2001 | 32 | 0.020 |
Why?
|
| Edema | 4 | 1993 | 66 | 0.020 |
Why?
|
| Glioblastoma | 2 | 2002 | 219 | 0.020 |
Why?
|
| Prostanoic Acids | 2 | 1987 | 9 | 0.020 |
Why?
|
| Movement Disorders | 2 | 1987 | 58 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 1991 | 208 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1993 | 705 | 0.020 |
Why?
|
| Brain Death | 1 | 1990 | 34 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1990 | 134 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 1990 | 42 | 0.020 |
Why?
|
| Lymphoma | 1 | 1990 | 116 | 0.020 |
Why?
|
| DNA Primers | 2 | 2000 | 302 | 0.020 |
Why?
|
| Hematoma | 1 | 1989 | 47 | 0.020 |
Why?
|
| Cathepsin D | 2 | 1986 | 13 | 0.020 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1989 | 43 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1990 | 305 | 0.020 |
Why?
|
| Rats, Inbred Lew | 2 | 2000 | 150 | 0.020 |
Why?
|
| Thalamus | 1 | 1989 | 82 | 0.020 |
Why?
|
| Cathepsins | 2 | 1986 | 37 | 0.020 |
Why?
|
| Alleles | 2 | 2002 | 386 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 1991 | 615 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2009 | 30 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2009 | 32 | 0.020 |
Why?
|
| Glycopeptides | 1 | 1988 | 15 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1988 | 42 | 0.020 |
Why?
|
| Arachidonic Acids | 1 | 1989 | 97 | 0.020 |
Why?
|
| Cycloheximide | 2 | 2001 | 50 | 0.020 |
Why?
|
| Theobromine | 1 | 1988 | 3 | 0.020 |
Why?
|
| Pentoxifylline | 1 | 1988 | 12 | 0.020 |
Why?
|
| Child | 4 | 1988 | 6405 | 0.020 |
Why?
|
| Mice, Inbred Strains | 3 | 1977 | 181 | 0.020 |
Why?
|
| Ricinus | 1 | 1987 | 2 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1987 | 27 | 0.020 |
Why?
|
| Soybeans | 1 | 1987 | 11 | 0.020 |
Why?
|
| 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 1987 | 3 | 0.020 |
Why?
|
| Moyamoya Disease | 1 | 1988 | 7 | 0.020 |
Why?
|
| Plants, Toxic | 1 | 1987 | 33 | 0.020 |
Why?
|
| Binding Sites | 1 | 1989 | 631 | 0.020 |
Why?
|
| Kidney | 1 | 1992 | 945 | 0.020 |
Why?
|
| Cations, Monovalent | 1 | 2007 | 4 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1987 | 50 | 0.020 |
Why?
|
| Gerbillinae | 1 | 2007 | 156 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 127 | 0.020 |
Why?
|
| Plasmids | 1 | 1988 | 258 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 67 | 0.020 |
Why?
|
| Peroxidase | 3 | 1992 | 40 | 0.020 |
Why?
|
| Acylation | 1 | 1986 | 22 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1988 | 134 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1988 | 314 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2002 | 756 | 0.020 |
Why?
|
| Glycine | 2 | 1977 | 89 | 0.020 |
Why?
|
| Viral Vaccines | 1 | 1986 | 17 | 0.020 |
Why?
|
| Influenza A virus | 1 | 1986 | 13 | 0.020 |
Why?
|
| Myocardium | 1 | 1992 | 1204 | 0.020 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 1986 | 4 | 0.020 |
Why?
|
| Eicosanoic Acids | 1 | 1986 | 3 | 0.020 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1986 | 29 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1986 | 86 | 0.020 |
Why?
|
| Carbohydrates | 2 | 1991 | 57 | 0.020 |
Why?
|
| Infarction | 1 | 1966 | 17 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 1966 | 36 | 0.020 |
Why?
|
| Neprilysin | 1 | 1986 | 55 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 1986 | 75 | 0.020 |
Why?
|
| Freezing | 1 | 1985 | 29 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 1986 | 56 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1966 | 137 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 1966 | 77 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1989 | 1745 | 0.020 |
Why?
|
| Fluorometry | 1 | 1984 | 7 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1984 | 18 | 0.020 |
Why?
|
| Organ Size | 2 | 1976 | 242 | 0.020 |
Why?
|
| Polyribosomes | 1 | 1984 | 24 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1990 | 94 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 1984 | 15 | 0.020 |
Why?
|
| Galactose Oxidase | 1 | 1984 | 3 | 0.020 |
Why?
|
| Borohydrides | 1 | 1984 | 3 | 0.020 |
Why?
|
| South Carolina | 2 | 1990 | 2752 | 0.020 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 2 | 1994 | 7 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 1984 | 23 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1984 | 79 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 1984 | 53 | 0.010 |
Why?
|
| Somatosensory Cortex | 2 | 1974 | 22 | 0.010 |
Why?
|
| Central Nervous System Diseases | 2 | 1975 | 40 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 1966 | 168 | 0.010 |
Why?
|
| G(M3) Ganglioside | 2 | 1980 | 7 | 0.010 |
Why?
|
| Adolescent | 3 | 1987 | 8912 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 248 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1984 | 36 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2003 | 22 | 0.010 |
Why?
|
| Cerebellum | 2 | 1996 | 103 | 0.010 |
Why?
|
| Hydroxylamines | 1 | 1983 | 20 | 0.010 |
Why?
|
| Muscle Cramp | 1 | 1982 | 3 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1984 | 567 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2002 | 32 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 31 | 0.010 |
Why?
|
| NADP | 1 | 1982 | 39 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1982 | 46 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1989 | 2324 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 2 | 1974 | 20 | 0.010 |
Why?
|
| Pedigree | 1 | 1982 | 159 | 0.010 |
Why?
|
| Rosette Formation | 2 | 1980 | 9 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1982 | 75 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2002 | 35 | 0.010 |
Why?
|
| Nucleotides, Cyclic | 2 | 1979 | 5 | 0.010 |
Why?
|
| Synapses | 2 | 1974 | 222 | 0.010 |
Why?
|
| Electromyography | 1 | 1982 | 184 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 207 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 1999 | 597 | 0.010 |
Why?
|
| G(M2) Ganglioside | 1 | 1980 | 1 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1980 | 62 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1987 | 2279 | 0.010 |
Why?
|
| Chemistry | 1 | 1980 | 45 | 0.010 |
Why?
|
| Pectoralis Muscles | 1 | 1980 | 12 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 1984 | 2791 | 0.010 |
Why?
|
| B-Lymphocytes | 2 | 1982 | 329 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 2000 | 10 | 0.010 |
Why?
|
| Xanthenes | 1 | 2000 | 18 | 0.010 |
Why?
|
| Nucleotidases | 1 | 1980 | 1 | 0.010 |
Why?
|
| Nucleosomes | 1 | 2000 | 25 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1980 | 97 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2000 | 36 | 0.010 |
Why?
|
| Oxidants | 1 | 2000 | 48 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1979 | 22 | 0.010 |
Why?
|
| Hydroxyl Radical | 1 | 1999 | 17 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 168 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 191 | 0.010 |
Why?
|
| Myelin P2 Protein | 2 | 1992 | 3 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1984 | 3187 | 0.010 |
Why?
|
| Pain | 1 | 1982 | 472 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2000 | 244 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 1999 | 52 | 0.010 |
Why?
|
| Synaptosomes | 1 | 1978 | 57 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1999 | 102 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 1998 | 11 | 0.010 |
Why?
|
| Acetates | 1 | 1978 | 74 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 97 | 0.010 |
Why?
|
| Half-Life | 1 | 1998 | 96 | 0.010 |
Why?
|
| Carotid Arteries | 2 | 1989 | 110 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1553 | 0.010 |
Why?
|
| Gene Expression | 1 | 2000 | 770 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1998 | 140 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1998 | 179 | 0.010 |
Why?
|
| Cerebral Arteries | 2 | 1987 | 50 | 0.010 |
Why?
|
| Serum Albumin | 2 | 1988 | 104 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1976 | 7 | 0.010 |
Why?
|
| Galactose | 2 | 1974 | 16 | 0.010 |
Why?
|
| Stage-Specific Embryonic Antigens | 1 | 1995 | 1 | 0.010 |
Why?
|
| Genotype | 1 | 1998 | 786 | 0.010 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1995 | 14 | 0.010 |
Why?
|
| Acute Disease | 2 | 1988 | 658 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1995 | 11 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1995 | 78 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1995 | 47 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1995 | 144 | 0.010 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1995 | 2 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 282 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1995 | 47 | 0.010 |
Why?
|
| Blood | 1 | 1995 | 40 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1975 | 37 | 0.010 |
Why?
|
| Optic Nerve | 1 | 1975 | 55 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1994 | 12 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1995 | 150 | 0.010 |
Why?
|
| Ceramidases | 1 | 1994 | 47 | 0.010 |
Why?
|
| Lead | 1 | 1974 | 45 | 0.010 |
Why?
|
| Amidohydrolases | 1 | 1994 | 60 | 0.010 |
Why?
|
| Body Weight | 1 | 1976 | 554 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1974 | 45 | 0.010 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 1993 | 5 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 1988 | 1738 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1988 | 848 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 307 | 0.010 |
Why?
|
| Iodoacetic Acid | 1 | 1992 | 6 | 0.010 |
Why?
|
| Iodoacetates | 1 | 1992 | 6 | 0.010 |
Why?
|
| Chromatography | 1 | 1972 | 47 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 54 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 1972 | 18 | 0.010 |
Why?
|
| Spleen | 1 | 1972 | 301 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1972 | 149 | 0.010 |
Why?
|
| Receptors, Fc | 2 | 1982 | 19 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1971 | 31 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1991 | 164 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 1991 | 7 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1991 | 8 | 0.010 |
Why?
|
| Xanthine Dehydrogenase | 1 | 1991 | 1 | 0.010 |
Why?
|
| Allopurinol | 1 | 1991 | 36 | 0.010 |
Why?
|
| Body Water | 1 | 1991 | 35 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1972 | 125 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1991 | 112 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1972 | 156 | 0.010 |
Why?
|
| Plasmalogens | 1 | 1970 | 8 | 0.010 |
Why?
|
| Colorimetry | 1 | 1970 | 22 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1989 | 19 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1989 | 65 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1989 | 78 | 0.010 |
Why?
|
| Biopsy | 1 | 1990 | 540 | 0.000 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1988 | 4 | 0.000 |
Why?
|
| Decapodiformes | 1 | 1988 | 3 | 0.000 |
Why?
|
| Dialysis | 1 | 1988 | 30 | 0.000 |
Why?
|
| Chlorides | 1 | 1988 | 68 | 0.000 |
Why?
|
| Placebos | 1 | 1988 | 195 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1990 | 418 | 0.000 |
Why?
|
| Sodium | 1 | 1988 | 161 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 442 | 0.000 |
Why?
|
| Oxygen | 1 | 1989 | 386 | 0.000 |
Why?
|
| Heart Rate | 1 | 1989 | 568 | 0.000 |
Why?
|
| Rheology | 1 | 1986 | 25 | 0.000 |
Why?
|
| Ligation | 1 | 1986 | 83 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1987 | 334 | 0.000 |
Why?
|
| Thromboxane-A Synthase | 1 | 1986 | 24 | 0.000 |
Why?
|
| Homeostasis | 1 | 1988 | 291 | 0.000 |
Why?
|
| Lumbosacral Region | 1 | 1966 | 18 | 0.000 |
Why?
|
| Paraplegia | 1 | 1966 | 28 | 0.000 |
Why?
|
| Catalysis | 1 | 1986 | 123 | 0.000 |
Why?
|
| Locomotion | 1 | 1987 | 135 | 0.000 |
Why?
|
| Aorta, Abdominal | 1 | 1966 | 97 | 0.000 |
Why?
|
| Intermediate Filaments | 1 | 1985 | 6 | 0.000 |
Why?
|
| Disability Evaluation | 1 | 1987 | 298 | 0.000 |
Why?
|
| Cats | 1 | 1985 | 292 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1986 | 284 | 0.000 |
Why?
|
| Pressoreceptors | 1 | 1984 | 15 | 0.000 |
Why?
|
| Water | 1 | 1985 | 230 | 0.000 |
Why?
|
| Recurrence | 1 | 1987 | 948 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1986 | 453 | 0.000 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 1983 | 14 | 0.000 |
Why?
|
| Metalloendopeptidases | 1 | 1984 | 67 | 0.000 |
Why?
|
| Lipoproteins | 2 | 1974 | 161 | 0.000 |
Why?
|
| Collodion | 1 | 1982 | 3 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1989 | 1451 | 0.000 |
Why?
|
| Diet | 1 | 1986 | 514 | 0.000 |
Why?
|
| Neural Pathways | 1 | 1984 | 324 | 0.000 |
Why?
|
| Temperature | 1 | 1983 | 341 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1990 | 2223 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1987 | 1851 | 0.000 |
Why?
|
| Pons | 1 | 1980 | 35 | 0.000 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1982 | 199 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1980 | 172 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1980 | 228 | 0.000 |
Why?
|
| Risk Factors | 1 | 1988 | 5731 | 0.000 |
Why?
|
| Fucose | 1 | 1974 | 25 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1974 | 36 | 0.000 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1974 | 24 | 0.000 |
Why?
|